The NICE Osteoarthritis Guideline Development Group (GDG) has been challenged for not using the available acupuncture evidence in the most appropriate manner in three crucial areas. This response explains the methods used by the GDG with particular reference to the economic analysis, and illustrates that the methods used were those most appropriate for developing a NICE clinical guideline. The cost-effectiveness conclusions made by the GDG are supported by the currently available evidence.
Get full access to this article
View all access options for this article.
References
1.
WhiteA.NICE guideline on osteoarthritis: is it fair to acupuncture? No. Acupunct Med2009;27:70–72.
2.
National Collaborating Centre for Chronic Conditions (NCCCC) on behalf of the National Institute for Health and Clinical Excellence. Osteoarthritis: National clinical guideline for care and management in adults. Royal College of Physicians, February 2008. http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf (accessed 21 Apr 2009).
3.
WhiteA, FosterNE, CummingsM, BarlasP.Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology (Oxford) 2007;46:384–90.
4.
ManheimerE, LindeK, LaoL, Meta-analysis: Acupuncture for osteoarthritis of the knee. Ann Intern Med2007;146:868–77.
5.
BermanBM, LaoL, LangenbergP, Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med2004;141:901–10.
6.
WittC, BrinkhausB, JenaS, Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet2005;366:136–43.
7.
ScharfHP, MansmannU, StreitbergerK, Acupuncture and knee osteoarthritis - a three-armed randomized trial. Ann Intern Med2006;145:12–20.
8.
National Collaborating Centre for Chronic Conditions (NCCCC) on behalf of the National Institute for Health and Clinical Excellence. Osteoarthritis: National clinical guideline for care and management in adults, Appendix D: Details of the NSAID/COX-2 inhibitor health economic model, Royal College of Physicians, February 2008. http://www.rcplondon.ac.uk (accessed 19 Apr 2009).
9.
LatimerN, LordJ, GrantR, Cost effectiveness of COX 2 inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. Br Med J. In press.
10.
National Institute for Health and Clinical Excellence. Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis, Technology Appraisal Guidance – No. 27, July 2001. http://www.nice.org.uk/nicemedia/pdf/coxiifullguidance.pdf (accessed 29 Apr 2008).
11.
Medicines and Healthcare products Regulatory Agency (MHRA), Pharmacovigilence Working Party (PhVWP) Assessment Report. Etoricoxib, Diclofenac. 8 September 2006.
12.
SilversteinFE, FaichG.Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. JAMA2000;284:1247–55.
13.
FarkouhME, KirschnerH.Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet2004;364:675–84.
14.
UnderwoodM, AshbyD, CarnesD, Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technol Assess2008;12:1–176.
15.
SangdeeC, TeekachunhateanS, SananpanichK, Electroacupuncture versus diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. BMC Complement Altern Med2002;2:3.
16.
National Institute for Health and Clinical Excellence, Guide to the Methods of Technology Appraisal. http://www.nice.org.uk (accessed Jun 2008).
17.
KaptchukTJ, KelleyJM, ConboyLA, Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ2008;336:999–1003.
18.
ReinholdT, WittCM, JenaS, Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain. Eur J Health Econ2008;9:209–19.
19.
WittCM, BrinkhausB, ReinholdT, Efficacy, effectiveness, safety and costs of acupuncture for chronic pain – results of a large research initiative. Acupunct Med2006;24(Suppl):S33–9.
